Suppr超能文献

SU-E-T-200:在线自适应放射治疗的调强放疗患者特异性质量保证

SU-E-T-200: IMRT Patient Specific QA for On-Line Adaptive Radiotherapy.

作者信息

Gao Z, Wong J, Merrick S, Karim M, Li M

机构信息

Morristown Memorial Hospital, Morristown, NJ.

出版信息

Med Phys. 2012 Jun;39(6Part12):3749. doi: 10.1118/1.4735260.

Abstract

PURPOSE

On-line adaptive IMRT requires a highly efficient radiotherapy team and an intensive amount of work, as well as significant amount of Quality Assurance (QA). With regard to patient specific QA, it is clinically unrealistic to perform fluence measurements via a QA phantom while patient is setup awaiting treatment. We therefore developed an alternative way to check point dose and the IMRT fluence right before beam delivery.

METHODS

In this study, 28 IMRT plans were generated with Prowess Panther 5.1 for three prostate cancer patients on 28 CT datasets with CTV and critical organs contoured by treating physicians. The corresponding QA plans were generated by Prowess, and then transfered to Pinnacle 9.2 for fluence recalculation on a flat surface phantom, In addition 28 QA plans were delivered on a Siemens Artiste accelerator and fluence were measured with Matrixx IMRT Device. We analyzed both point dose and fluence for these 28 samples.

RESULTS

Of all 28 IMRT plans, the point dose difference between Prowess and Pinnacle are well within 1%. The point dose difference between measurements and Prowess calculation are all within 3%. The passing rates using gamma criteria (3%3mm) for the fluence comparison between Prowess and Pinnacle calculation are at least 98.5% while the passing rates of the gamma analysis between fluence measurement and Prowess calculation are all better than 98.5%. The passing rate of gamma difference between Prowess vs Pinnacle and Prowess vs QA measurement is less than 1.5% for all 28 samples. Therefore, second TPS (e.g. Pinnacle) can be used to verify planned fluencies and can serve as a valuable patient specific QA when conventional IMRT QA measurement is not feasible.

CONCLUSIONS

A new IMRT plan is desired if significant anatomy change from the date of original CT scan is observed before the radiation delivery. It is not clinically feasible to check the fluence on the machine before radiation delivery while the patient is in the treatment suite awaiting radiation delivery. Our method showed here is an alternative way to verify the planned fluence with a second TPS and can serve as a valuable IMRT patient specific QA in online adaptive radiotherapy.

摘要

目的

在线自适应调强放疗(IMRT)需要高效的放疗团队和大量的工作,以及大量的质量保证(QA)。关于患者特异性QA,在患者摆位等待治疗时通过QA模体进行注量测量在临床上是不现实的。因此,我们开发了一种在束流照射前检查点剂量和IMRT注量的替代方法。

方法

在本研究中,使用Prowess Panther 5.1为3例前列腺癌患者的28个CT数据集生成了28个IMRT计划,靶区(CTV)和危及器官由治疗医师勾画。相应的QA计划由Prowess生成,然后传输到Pinnacle 9.2在平面模体上重新计算注量。此外,在西门子Artiste加速器上执行28个QA计划,并使用Matrixx IMRT设备测量注量。我们分析了这28个样本的点剂量和注量。

结果

在所有28个IMRT计划中,Prowess和Pinnacle之间的点剂量差异均在1%以内。测量值与Prowess计算值之间的点剂量差异均在3%以内。使用γ标准(3%3mm)进行Prowess与Pinnacle计算之间注量比较的通过率至少为98.5%,而注量测量与Prowess计算之间γ分析的通过率均优于98.5%。对于所有28个样本,Prowess与Pinnacle之间以及Prowess与QA测量之间γ差异的通过率均小于1.5%。因此,当传统的IMRT QA测量不可行时,第二个治疗计划系统(例如Pinnacle)可用于验证计划的注量,并可作为有价值的患者特异性QA。

结论

如果在放疗前观察到自原始CT扫描日期起有显著的解剖结构变化,则需要新的IMRT计划。当患者在治疗室等待放疗时,在放疗前在机器上检查注量在临床上是不可行的。我们在此展示的方法是使用第二个治疗计划系统验证计划注量的替代方法,并且可作为在线自适应放疗中有价值的IMRT患者特异性QA。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验